Cardiff Oncology Income Statement (2011-2025) | CRDF

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.07M	0.07M	0.09M	0.13M	0.07M	0.09M	0.09M	0.13M	0.08M	0.11M	0.14M	0.16M	0.20M	0.16M	0.17M	0.15M	0.11M	0.12M	0.12M	0.24M
Gross Profit (Quarter)
Operating items
Amortization - Deferred Charges (Quarter)
Research & Development (Quarter)	3.28M	4.12M	4.15M	5.82M	7.21M	7.45M	6.01M	6.44M	9.05M	8.02M	8.02M	7.76M	8.01M	9.49M	9.64M	9.71M	10.48M	11.58M	8.20M	5.08M
Selling, General & Administrative (Quarter)	2.23M	2.84M	2.93M	3.83M	3.94M	3.09M	3.08M	3.08M	3.08M	4.30M	2.94M	2.73M	3.13M	3.21M	3.13M	3.01M	4.01M	3.32M	3.90M	3.00M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	5.51M	6.96M	7.08M	9.66M	11.15M	10.53M	9.09M	9.52M	12.13M	12.32M	10.96M	10.49M	11.14M	12.71M	12.77M	12.72M	14.49M	14.90M	12.09M	8.07M
Operating Income (Quarter)	-5.44M	-6.89M	-7.00M	-9.53M	-11.07M	-10.44M	-8.99M	-9.39M	-12.05M	-12.21M	-10.82M	-10.33M	-10.93M	-12.54M	-12.60M	-12.57M	-14.38M	-14.78M	-11.97M	-7.83M
EBIT (Quarter)	-5.44M	-6.89M	-7.00M	-9.53M	-11.07M	-10.44M	-8.99M	-9.39M	-12.05M	-12.21M	-10.82M	-10.33M	-10.93M	-12.54M	-12.60M	-12.57M	-14.38M	-14.78M	-11.97M	-7.83M
Non-operating items
Interest & Investment Income (Quarter)										1.05M	1.07M	1.01M	0.93M	0.81M	0.74M	0.79M	0.94M	0.83M	0.72M	0.61M
Other Non Operating Income (Quarter)	0.21M	0.06M	0.00M	0.27M	-0.05M	-0.25M	-0.04M	-0.04M	-0.11M	0.01M	0.02M	-0.01M	-0.00M	-0.04M	0.01M	-0.00M	0.01M	-0.00M		-0.00M
Non Operating Income (Quarter)	0.26M		0.00M	0.08M	-0.05M	-0.25M	0.42M	0.69M	0.83M	0.01M	0.02M	-0.01M	0.92M	0.77M	0.75M	-2.47M	0.01M	-0.00M	0.72M	-2.49M
Net income details
EBT (Quarter)	-5.44M	-6.89M	-7.00M	-9.53M	-11.07M	-10.44M	-8.99M	-9.39M	-12.05M	-11.15M	-9.75M	-9.32M	-10.01M	-11.74M	-11.86M	-11.79M	-13.44M	-13.94M	-11.26M	-7.21M
Profit After Tax (Quarter)	-5.18M	-6.76M	-6.91M	-9.44M	-10.99M	-10.44M	-8.57M	-8.70M	-11.22M	-11.15M	-9.73M	-9.34M	-10.01M	-11.78M	-11.86M	-11.79M	-13.43M	-13.94M	-11.26M	-7.22M
Income from Continuing Operations (Quarter)	-5.44M	-6.89M	-7.00M	-9.53M	-11.07M	-10.44M	-8.99M	-9.39M	-12.05M	-11.15M	-9.75M	-9.32M	-10.01M	-11.74M	-11.86M	-11.79M	-13.44M	-13.94M	-11.26M	-7.21M
Consolidated Net Income (Quarter)	-5.44M	-6.89M	-7.00M	-9.53M	-11.07M	-10.44M	-8.99M	-9.39M	-12.05M	-11.15M	-9.75M	-9.32M	-10.01M	-11.74M	-11.86M	-11.79M	-13.44M	-13.94M	-11.26M	-7.21M
Income towards Parent Company (Quarter)	-5.44M	-6.89M	-7.00M	-9.53M	-11.07M	-10.44M	-8.99M	-9.39M	-12.05M	-11.15M	-9.75M	-9.32M	-10.01M	-11.74M	-11.86M	-11.79M	-13.44M	-13.94M	-11.26M	-7.21M
Preferred Dividend Payments (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Net Income towards Common Stockholders (Quarter)	-5.18M	-6.76M	-6.92M	-9.45M	-11.00M	-10.45M	-8.58M	-8.70M	-11.23M	-11.16M	-9.74M	-9.34M	-10.02M	-11.78M	-11.86M	-11.79M	-13.44M	-13.95M	-11.26M	-7.22M
Additional items
EPS (Basic) (Quarter)	-0.14	-0.17	-0.17	-0.24	-0.25	-0.24	-0.20	-0.20	-0.25	-0.25	-0.22	-0.21	-0.22	-0.26	-0.25	-0.21	-0.20	-0.21	-0.17	-0.11
EPS (Weighted Average and Diluted) (Quarter)	-0.14	-0.17	-0.17	-0.24	-0.25	-0.24	-0.20	-0.20	-0.25	-0.25	-0.22	-0.21	-0.22	-0.26	-0.25	-0.21	-0.20	-0.21	-0.17	-0.11
Shares Outstanding (Weighted Average) (Quarter)	37.16M	38.76M	4.49M	4.49M	43.23M	4.49M	43.33M	4.36M	44.68M	2.81M	44.68M	2.81M	2.81M	44.75M	2.81M	2.81M	66.52M	66.53M	1.08M	66.84M
Shares Outstanding (Diluted Average) (Quarter)	37.16M	37.97M	38.50M	39.03M	43.23M	43.31M	43.33M	43.60M	44.68M	44.68M	44.68M	44.68M	44.68M	44.75M	46.87M	47.65M	66.52M	66.53M	66.88M	66.84M
EBITDA (Quarter)	-5.44M	-6.89M	-7.00M	-9.53M	-11.07M	-10.44M	-8.99M	-9.39M	-12.05M	-12.21M	-10.82M	-10.33M	-10.93M	-12.54M	-12.60M	-12.57M	-14.38M	-14.78M	-11.97M	-7.83M
Interest Expenses (Quarter)
Shares Outstanding (Quarter)	37.55M	0.72M	39.55M	0.72M	0.39M	0.39M	43.34M	44.68M	44.68M	44.68M	44.68M	0.06M	0.06M	45.60M	0.06M	66.52M	66.53M	66.53M	67.09M	68.31M

Research Tools

Cardiff Oncology Income Statement (2011-2025) | CRDF

Create an account

Sign In

Reset Password